




Searching News Database: deuterated chemical entity
HSMN NewsFeed - 4 Feb 2015
Concert Pharmaceuticals Announces Appointment of James V. Cassella as Chief Development Officer
Concert Pharmaceuticals Announces Appointment of James V. Cassella as Chief Development Officer
HSMN NewsFeed - 23 Jan 2014
Concert Pharmaceuticals Announces the Appointment of Ryan Daws as Chief Financial Officer
Concert Pharmaceuticals Announces the Appointment of Ryan Daws as Chief Financial Officer
HSMN NewsFeed - 19 Jan 2011
James E. Shipley, M.D., Named Chief Medical Officer of Concert Pharmaceuticals
James E. Shipley, M.D., Named Chief Medical Officer of Concert Pharmaceuticals